The impact of transforming growth factor-β1 gene polymorphism on end-stage renal failure after heart transplantation

Transplantation

Volumn 82, Issue 12, 2006, Pages 1744-1748

  Van De Wetering, Jacqueline ^a   Weimar, Charlotte H E ^a   Balk, Aggie H M M ^a   Roodnat, Joke I ^a   Holweg, Cécile T J ^a   Baan, Carla C ^a   Van Domburg, Ron T ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Calcineurin inhibitor; Heart transplantation; Renal failure

Indexed keywords

ARGININE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; LEUCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROLINE; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; CODON; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENETIC RISK; GENOTYPE; GRAFT VERSUS HOST REACTION; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; CALCINEURIN; CHILD; CHILD, PRESCHOOL; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33845951304     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250360.78553.5e     Document Type: Conference Paper

References (32)

1. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 2005; 24(8): 945.
2. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349(10): 931.
3. Satchithananda DK, Parameshwar J, Sharples L, et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002; 21(6): 651.
4. Goldstein DJ, Zuech N, Sehgal V, et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997; 63(5): 664.
5. Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center. Clin Transplant 1997; 11(1): 1.
6. Al Aly Z, Abbas S, Moore E, et al. The natural history of renal function following orthotopic heart transplant. Clin Transplant 2005; 19(5): 683.
7. Goral S, Ynares C, Shyr Y, et al. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant 1997; 16(11): 1106.
8. Gonwa TA, Mai ML, Pilcher J, et al. Stability of long-term renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992; 11(5): 926.
9. van Gelder T, Balk AH, Zietse R, et al. Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998; 13(9): 2322.
10. Zietse R, Balk AH, vd Dorpel MA, et al. Time course of the decline in renal function in cyclosporine-treated heart transplant recipients. Am J Nephrol 1994; 14(1): 1.
11. Senechal M, Dorent R, du Montcel ST, et al. End-stage renal failure and cardiac mortality after heart transplantation. Clin Transplant 2004; 18(1): 1.
12. Herlitz H, Lindelow B. Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000; 15(3): 311.
13. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006; 6(4): 671.
14. Lindelow B, Bergh CH, Herlitz H, Waagstein F. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000; 11(5): 951.
15. Garrido IP, Crespo-Leiro MG, Paniagua MJ, et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant 2005; 24(9): 1226.
16. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66(8): 1014.
17. Li B, Khanna A, Sharma V, et al. TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33 (1 Pt 2): 271.
18. Baan CC, Balk AH, Holweg CT, et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant 2000; 19(9): 866.
19. Wabbijn M, Balk AH, van Domburg RT, et al. Ten-year follow-up of recipients of a kidney or heart transplant who received induction therapy with a monoclonal antibody against the interleukin-2 receptor. Exp Clin Transplant 2004; 2(1): 201.
20. Holweg CT, Baan CC, Niesters HG, et al. TGF-beta1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant 2001; 20(9): 979.
21. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331(19): 1286.
22. Pankewycz OG, Miao L, Isaacs R, et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 1996; 50(5): 1634.
23. Shin GT, Khanna A, Ding R, et al. In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. Transplantation 1998; 65(3): 313.
24. Nicholson ML, Bicknell GR, Barker G, et al. Intragraft expression of transforming growth factor beta1 gene in isolated glomeruli from human renal transplants. Br J Surg 1999; 86(9): 1144.
25. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998; 13(10): 1569.
26. El-Gamel A, Awad MR, Hasleton PS, et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 1999; 18(6): 517.
27. Wang XL, Sim AS, Wilcken DE. A common polymorphism of the transforming growth factor-beta1 gene and coronary artery disease. Clin Sci (Lond) 1998; 95(6): 745.
28. Syrris P, Carter ND, Metcalfe JC, et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998; 95(6): 659.
29. Lim CS, Kim YS, Chae DW, et al. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin Nephrol 2005; 63(2): 61.
30. Solari V, Owen D, Puri P. Association of transforming growth factor-beta1 gene polymorphism with reflux nephropathy. J Urol 2005; 174 (4 Pt 2): 1609.
31. Holweg CT, Baan CC, Balk AH, et al. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001; 71(10): 1463.
32. Di Filippo S, Zeevi A, McDade KK, et al. Impact of TGFbeta1 gene polymorphisms on acute and chronic rejection in pediatric heart transplant allografts. Transplantation 2006; 81(6): 934.